Recruiting NCT06964308
Thoracoscopic Pleural Biopsy in Sohag University Hospital
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: thoracoscopic pleural biopsy..
- Who it may be relevant to
- Registry conditions: Pleural Diseases. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Thoracoscopic Pleural Biopsy, Sohag University Hospital
Overview
This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.
Interventions
- Procedure thoracoscopic pleural biopsy.
This intervention aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.
Primary outcome measures
- early postoperative follow up for thoracoscopic pleural biopsy in the management of pleural diseases. [Time frame: 3 days after procedure]
Eligibility criteria
Inclusion criteria
- Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy
- Age: Adults aged 18 years and older
- Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.
Exclusion criteria
- Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy
- Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy).
- Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation.
- Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations.
- Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons.
- Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
Egypt · 1 center
- Sohag University Hospital — Sohag
Publications
- Solari E, Marcozzi C, Ottaviani C, Negrini D, Moriondo A. Draining the Pleural Space: Lymphatic Vessels Facing the Most Challenging Task. Biology (Basel). 2022 Mar 10;11(3):419. doi: 10.3390/biology11030419. PMID 35336793
- Yao X, Abd Hamid M, Sundaralingam A, Evans A, Karthikappallil R, Dong T, Rahman NM, Kanellakis NI. Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases. Breathe (Sheff). 2020 Dec;16(4):200203. doi: 10.1183/20734735.0203-2020. PMID 33447289
- Shaikh F, Lentz RJ, Feller-Kopman D, Maldonado F. Medical thoracoscopy in the diagnosis of pleural disease: a guide for the clinician. Expert Rev Respir Med. 2020 Oct;14(10):987-1000. doi: 10.1080/17476348.2020.1788940. Epub 2020 Jul 12. PMID 32588676
Identifiers
NCT: NCT06964308 · Soh-Med--25-2-03MS